D.E. Shaw & Co’s CytRx Corp CYTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-60,360
Closed -$63K 4201
2018
Q3
$63K Sell
60,360
-9,604
-14% -$10.8K ﹤0.01% 3647
2018
Q2
$79K Sell
69,964
-75,822
-52% -$113K ﹤0.01% 3630
2018
Q1
$232K Sell
145,786
-173,646
-54% -$305K ﹤0.01% 3263
2017
Q4
$540K Sell
319,432
-5,045
-2% -$10.4K ﹤0.01% 2945
2017
Q3
$798K Buy
324,477
+322,285
+14,703% +$1.09M ﹤0.01% 2639
2017
Q2
$8K Sell
2,192
-25,641
-92% -$87.6K ﹤0.01% 3330
2017
Q1
$74K Sell
27,833
-8,075
-22% -$20.4K ﹤0.01% 3207
2016
Q4
$81K Sell
35,908
-13,689
-28% -$40.2K ﹤0.01% 3361
2016
Q3
$175K Buy
49,597
+46,009
+1,282% +$211K ﹤0.01% 3222
2016
Q2
$48K Sell
3,588
-11,245
-76% -$187K ﹤0.01% 3289
2016
Q1
$239K Buy
14,833
+6,424
+76% +$87.8K ﹤0.01% 3118
2015
Q4
$134K Buy
+8,409
New +$144K ﹤0.01% 3640
2015
Q1
Sell
-4,317
Closed -$71K 4351
2014
Q4
$71K Buy
+4,317
New +$67.3K ﹤0.01% 3927
2014
Q3
Sell
-3,817
Closed -$96K 4694
2014
Q2
$96K Buy
+3,817
New +$87K ﹤0.01% 4086

Other funds holding CYTR

D.E. Shaw & Co's CYTR Position: Q4 2018 in Review

D.E. Shaw & Co sold out of CytRx Corp (CYTR) in Q4 2018, closing a stake of 60,360 shares — an estimated $63K sold.

D.E. Shaw & Co first reported a position in CYTR in Q2 2014 and held it in 14 quarters. The position peaked at $798K in Q3 2017. 36 funds tracked by Wall St. Rank hold CYTR as of Q4 2018.

  • D.E. Shaw & Co reported no remaining CytRx Corp position as of Q4 2018 after selling out during the quarter.
  • D.E. Shaw & Co sold 60,360 CytRx Corp shares in Q4 2018, an estimated $63K.
  • D.E. Shaw & Co first reported a position in CytRx Corp in Q2 2014 and held it in 14 quarters.
  • D.E. Shaw & Co's CytRx Corp position peaked at $798K in Q3 2017.
  • 36 funds tracked by Wall St. Rank held CytRx Corp as of Q4 2018.

Based on D.E. Shaw & Co's 13F filing for Q4 2018, filed 14 Feb 2019.